Question of the Day – Thursday March 16, 2017

Question: What is the scientific basis for using nails (fingernails and/or toe nails) as a testing matrix for detecting drugs?

Read More...

Question of the Day – Wednesday March 15, 2017

Question: Hepatic veno-occlusive disease (HVOD) has been reported as a complication of herbals that contain pyrrolizidine alkaloids. What are the clinical characteristics of hepatic veno-occlusive disease?

Read More...

Question of the Day – Tuesday March 14, 2017

Question: What is “iodide mumps”?

Read More...

Question of the Day – Monday March 13, 2017

Question: Loperamide is an antidiarrheal agent available as an over the counter drug available to the public without a prescription. What is the mechanism by which this drug reduces diarrhea?

Read More...

Question of the Day – Friday March 10, 2017

Question: What are the factors that affect health care worker exposures to potentially hazardous antineoplastic drugs?

Read More...

Question of the Day – Thursday March 9, 2017

Question: As part of their risk management strategy for certain drugs, the Food and Drug Administration (FDA) requires a so-called “Risk Evaluation and Mitigation Strategy (REMS)”. What does a REMS include?

Read More...

Question of the Day – Wednesday March 8, 2017

Question: The concentration of melanin in human hair is recognized as affecting the amount of some drugs that might be incorporated into hair. As a consequence, at co-equal doses, higher drug levels are typically found in the hair of individuals with darker colored hair. This influence is particularly pronounced for which class of drugs?

Read More...

Question of the Day – Tuesday March 7, 2017

Question: One population-based cohort study of older adults, observed that new use of an atypical antipsychotic drug was associated with a higher 90-day risk for hospitalization with acute kidney injury (AKI). What are the potential causes for this observed effect?

Read More...

Question of the Day – Monday March 6, 2017

Question: A recent analysis of counterfeit OxyContin seized in Canada demonstrated fentanyl to be present in 89% of all tablets. Fentanyl is also often found in counterfeit alprazolam as well as other counterfeit medications. Why is fentanyl apparently used so often in the production of…

Question: A recent analysis of counterfeit OxyContin seized in Canada demonstrated fentanyl to be present in 89% of all tablets. Fentanyl is also often found in counterfeit alprazolam as well as other counterfeit medications. Why is fentanyl apparently used so often in the production of illicit street drugs?

Read More...

Question of the Day – Friday March 3, 2017

Question: What is the “exposome”?

Read More...

Site Search